Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2181

Actual shortage: 187 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 8 (0%)
Resolved: 1986 (91%)

Discontinuation Reports

349

To be discontinued: 20 (6%)
Discontinued: 329 (94%)
Reversed: 0 (0%)

Late reports

130 (5%)

Overdue reports

20 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-03-11 2017-05-23 466
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2017-04-11 2017-05-25 6516
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2017-06-06 2017-07-17 12059
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2017-06-15 2017-07-26 12805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-07-11 2017-07-27 15375
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-09-04 2018-07-31 20882
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-02-12 34844
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-03-06 34847
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-05-01 40351
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-04-16 2018-05-14 46024
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-12-28 54297
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-07-17 54309
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-01-08 2019-02-14 71475
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-02-13 2019-02-21 75617
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-06-26 2019-08-19 87512
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-07-03 2019-08-19 88331
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-10-28 92968
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-11-11 92971
APO-DICLO 50MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-12-09 95861

Showing 1961 to 1980 of 2181

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE - CAP 10MG 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE - CAP 25MG 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 349